Found 27 matching trials
Dose Escalation Study of Pazopanib Plus TH-302 PHASE1 3 STUDY RATIONALE Based upon the above rationale, the investigators propose...
Show More Location
Duke Cancer Institute
Learn More & Join Trial
SARC021C: A Continuation Study of TH-CR-406/SARC021 N/A SARC021C is a nonrandomized, open-label, multicenter, continuation study de...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab PHASE2 The Primary Objectives are:
* To determine the extent by which TH-302 is a...
Show More Location
Cancer Therapy & Research Center at UTHSCSA
Learn More & Join Trial
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer PHASE1 This is a multicenter, open-label, Phase 1, dose escalation trial to evalua...
Show More Learn More & Join Trial
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma PHASE1 This phase 2 study is designed to evaluate the safety and tolerability acti...
Show More Location
Pacific Cancer Care
Learn More & Join Trial
TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma PHASE1 The primary objective of this phase I dose escalation study is to determine...
Show More Learn More & Join Trial
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery PHASE1 RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blockin...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer PHASE2 The purpose of this study is to determine whether TH-302 in combination wit...
Show More Location
UAB Cancer Center
Learn More & Join Trial
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. PHASE1 Open-label, single-center phase 1 study of an investigational agent TH-302 ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma PHASE3 The purpose of this study is to determine whether TH-302 in combination wit...
Show More Learn More & Join Trial